The Biden Administration supports legislation restricting the application of utilization management requirements and eliminating cost sharing for pre-exposure prophylaxis against HIV infection in Medicaid to expand the treatments' use.
The administration endorses action that “requires states to cover pre-exposure prophylaxis (PrEP) and associated laboratory services with no cost sharing for Medicaid and CHIP beneficiaries, and places guardrails on utilization management practices, like prior authorization and step therapy, that can pose barriers to access and utilization of PrEP,” according to the fiscal year 2024